Relevance of Physiologically Based Biopharmaceutical Modeling (PBBM) in the Approval of Generic Products

Authors: Suarez-Sharp S
Keywords: FDA Office of Generic Drugs, generic drug products, generic drugs, PBBM modeling, PBPK, physiological based biopharmaceutics models (PBBM)
Software: GastroPlus®
Division: Simulations Plus

The Webinar “Relevance of Physiologically Based Biopharmaceutical Modeling (PBBM) in the Approval of Generic Products”, which will be presented in Spanish by Dr. Sandra Suárez-Sharp, Vice President – Regulatory Affairs at Simulations Plus, Inc.

This program is a joint effort between RedIF and Simulations Plus, Inc